Omnicell (OMCL) Non Operating Investment Income (2015)
Omnicell's (OMCL) quarterly Non Operating Investment Income came in at $3.4 million in Q2 2015.
Powered by 
Analysis
Omnicell (OMCL) Non Operating Investment Income (2015) Analysis & Trends
Omnicell (OMCL) has reported Non Operating Investment Income for 1 consecutive years, with $3.4 million the latest figure, recorded in Q2 2015.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $3.4 million in Q2 2015; TTM through Dec 2015 was $3.4 million, a N/A change from a year earlier, with the FY2015 full-year figure at $3.4 million, changed N/A from the prior year.
- Non Operating Investment Income was $3.4 million for Q2 2015 at Omnicell.
- Over five years, Non Operating Investment Income peaked at $3.4 million in Q2 2015 and troughed at $3.4 million in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 1.00 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | - |